Reciprocal interplay between OTULIN-LUBAC determines genotoxic and inflammatory NF-κB signal responses

Proc Natl Acad Sci U S A. 2022 Aug 16;119(33):e2123097119. doi: 10.1073/pnas.2123097119. Epub 2022 Aug 8.

Abstract

Targeting nuclear factor-kappa B (NF-κB) represents a highly viable strategy against chemoresistance in cancers as well as cell death. Ubiquitination, including linear ubiquitination mediated by the linear ubiquitin chain assembly complex (LUBAC), is emerging as a crucial mechanism of overactivated NF-κB signaling. Ovarian tumor family deubiquitinase OTULIN is the only linear linkage-specific deubiquitinase; however, the molecular mechanisms of how it counteracts LUBAC-mediated NF-κB activation have been largely unknown. Here, we identify Lys64/66 of OTULIN for linear ubiquitination facilitated in a LUBAC-dependent manner as a necessary event required for OTULIN-LUBAC interaction under unstressed conditions, which becomes deubiquitinated by OTULIN itself in response to genotoxic stress. Furthermore, this self-deubiquitination of OTULIN occurs intermolecularly, mediated by OTULIN dimerization, resulting in the subsequent dissociation of OTULIN from the LUBAC complex and NF-κB overactivation. Oxidative stress induces OTULIN dimerization via cysteine-mediated covalent disulfide bonds. Our study reveals that the status of the physical interaction between OTULIN and LUBAC is a crucial determining factor for the genotoxic NF-κB signaling, as measured by cell survival and proliferation, while OTULIN loss of function resulting from its dimerization and deubiquitination leads to a dissociation of OTULIN from the LUBAC complex. Of note, similar molecular mechanisms apply to the inflammatory NF-κB signaling in response to tumor necrosis factor α. Hence, a fuller understanding of the detailed molecular mechanisms underlying the disruption of the OTULIN-LUBAC interaction will be instrumental for developing future therapeutic strategies against cancer chemoresistance and necroptotic processes pertinent to numerous human diseases.

Keywords: LUBAC; NF-κB; OTULIN; deubiquitinases; inflammation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • DNA Damage*
  • Deubiquitinating Enzymes* / genetics
  • Deubiquitinating Enzymes* / metabolism
  • Drug Resistance, Neoplasm
  • Endopeptidases* / genetics
  • Endopeptidases* / metabolism
  • Humans
  • Inflammation* / enzymology
  • Inflammation* / genetics
  • NF-kappa B* / metabolism
  • Necroptosis
  • Protein Multimerization
  • Signal Transduction
  • Ubiquitin-Protein Ligase Complexes* / metabolism
  • Ubiquitination

Substances

  • NF-kappa B
  • Ubiquitin-Protein Ligase Complexes
  • Endopeptidases
  • OTULIN protein, human
  • Deubiquitinating Enzymes